Prediabetes remission possible without dropping pounds, new study finds
There's a long-held belief in diabetes prevention that weight loss is the main way to lower disease risk. Our new study challenges this.
Oct 4, 2025
0
139
Endocrine System Diseases: News and Research on Prediabetic State
MeSH tree: C19.246.774
Older adults with prediabetes and less education face higher cardiovascular complication risk
It's estimated that nearly half of adults aged 65 and older are living with prediabetes, a condition that predisposes them to developing type 2 diabetes and puts them at higher risk for cardiovascular complications.
Oct 1, 2025
0
10
For people without diabetes, continuous glucose monitors may not accurately reflect blood sugar control
Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type 2 diabetes improve blood sugar control. In 2024, the U.S. Food and Drug Administration approved ...
Oct 1, 2025
0
19
Blood sugar level is more important than body weight for lowering diabetes risk, study finds
Until now, weight reduction has been the primary therapeutic goal for people with prediabetes. An analysis of a large Tübingen study shows that patients who bring their blood sugar levels back within the normal range through ...
Sep 29, 2025
0
66
Can a mango a day keep diabetes away?
If presented with two snacks, one containing 7 grams of sugar and another with over 30 grams of sugar, choosing the healthier option should be a no-brainer, correct? Well, maybe not. Less sugar is not automatically healthier.
Sep 25, 2025
0
50
GLP-1 receptor agonists improve glycemic and weight outcomes in children with type 2 diabetes, finds study
In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic, weight, and cardiometabolic outcomes, according to a study published in JAMA Pediatrics.
Sep 23, 2025
0
11
Pill form of semaglutide may be a suitable option for adults with overweight or obesity, trial suggests
A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 weeks in adults with overweight or obesity.
'Light-touch' EHR referral strategy connects patients with prediabetes to community-based diabetes prevention programs
A recent study tested whether a referral order inside the Epic electronic health record (EHR) could help primary care clinicians refer patients to community-based diabetes prevention programs (DPPs), an important public health ...
Sep 23, 2025
0
12
Timing last evening meals is critical for people with prediabetes, study suggests
The way glucose is regulated at night plays a key role in fasting glucose levels the next morning, when blood sugar is expected to be at its lowest. This indicator is particularly important in people with dysglycemia, which ...
Sep 18, 2025
0
94
Antipsychotic-treated patients with schizophrenia see benefits from semaglutide, study claims
A multicenter collaboration of Danish researchers reports that once-weekly semaglutide for 30 weeks lowered blood sugar levels and body weight and improved physical quality of life in antipsychotic-treated adults with schizophrenia ...
